Medicine for treating tuberdulosis and lung disease and its preparing method

Abstract

The medicine is capsule or tablet prepared with forrest silkvine root, astragalus root and ophiopogon root as material through unique preparation process. It has the functions of resisting cystic disease, killing tubercule bacillus, tonifying deficiency and bacteriostasis. It has unique curative effect on tuberculosis and lung-originated heart disease and no medicine resistance. It has effective components for strengthening body's immunity, such as cardenolide, baicalin A, astagalus polysaccharide, etc.

Description

technical field [0001] The invention relates to a medicine for treating tuberculosis and lung disease, specifically a Chinese patent medicine prepared from Chinese herbal medicines, mainly used for treating tuberculosis (and other tuberculosis), pneumonia, pulmonary edema, and acute and chronic bronchitis. It also relates to a preparation method of the medicine. Background technique [0002] Tuberculosis is an ancient global chronic infectious disease. Before the 1840s, it was a highly contagious and difficult-to-cure disease. Since the advent of streptomycin, isoniazid, rifampicin and other anti-tuberculosis drugs , the cure rate of tuberculosis has reached over 95%, and the case fatality rate has dropped below the control line. Since the 1980s, tuberculosis has made a comeback around the world, and the epidemic has rebounded. The main reason is: affected by the biological variation of tuberculosis strains, highly effective anti-tuberculosis drugs such as isoniazid, strept...

AI Technical Summary

Problems solved by technology

[0004] For the treatment of tuberculosis, countries around the world currently implement a western medicine chemotherapy regimen based on isoniazid and rifampicin combined with 2-5 anti-tuberculosis drugs. However, isoniazid and rifampin are used alone or in combination3 After one month, the drug resistance will increase month by month, and the bactericidal and antibacterial effects will decrease significantly. Continuous drug use will cause neurotoxicity and liver and kidney damage. The urine of patients with tuberculosis drugs is yellow. Continuous drug use can lead to drug-induced hepatitis, renal failure and other diseases. It needs to be used in combination with drugs that protect the liver and kidney. Streptomycin has strong auditory neurotoxicity. Continuous drug use can lead to lifelong deafness and hearing loss. These toxic and side effects and the emergence of drug resistance seriously affect the drug tolerance of patients, and they have to switch to second-line and third-line anti-tuberculosis drugs for treatment. The second-line and third-line anti-tuberculosis chemotherapy drugs currently on the market, such as B The bactericidal and antibacterial effects of ambutol and the like are lower than those of the above-mentioned drugs, and there are disadvantages such as long course of treatment, high cost of medicine, low cure rate, etc.

[0005] At present, some Chinese patent medicines that are newly listed, such as anti-tuberculosis granules, Qibei capsules, etc., have very little toxic and side effects, and most of them have a good effect on enhancing immune and disease resistance. There are no pure Chinese preparations with bactericidal and antibacterial effects similar to rifampicin, isoniazid and other chemotherapeutic drugs.